Acute vertebral fracture

Journal of Hospital Medicine

Volumn 4, Issue 7, 2009, Pages

  Agulnek, Abby N ^a   O'Leary, Kevin J ^a   Edwards, Beatrice J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Fracture; Kyphoplasty; Osteoporosis; Osteoporosis fracture; Spine fracture; Vertebral compression fracture; Vertebral fracture; Vertebroplasty

Indexed keywords

ALENDRONIC ACID; BETA ENDORPHIN; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; IBANDRONIC ACID; LEVOTHYROXINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PREDNISONE; RISEDRONIC ACID; SALCATONIN; THYROTROPIN; ZOLEDRONIC ACID;

ANALGESIA; ANAMNESIS; BONE DENSITY; BONE MASS; BONE PAIN; CALCIUM INTAKE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CREATININE CLEARANCE; ESOPHAGITIS; EVIDENCE BASED MEDICINE; FRAGILITY FRACTURE; HUMAN; HYPOTHYROIDISM; KYPHOPLASTY; LOW BACK PAIN; LUMBAR VERTEBRA; LUNG FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PAIN; PERCUTANEOUS VERTEBROPLASTY; PHYSICAL ACTIVITY; PNEUMONIA; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RHEUMATIC POLYMYALGIA; SPINE RADIOGRAPHY; THORAX RADIOGRAPHY; THYROTROPIN BLOOD LEVEL; VERTEBRA FRACTURE; VITAMIN SUPPLEMENTATION;

AGED; ANALGESICS; BIOLOGICAL MARKERS; BONE DENSITY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LUMBAR VERTEBRAE; OSTEOPOROSIS; PHYSICAL THERAPY MODALITIES; SPINAL FRACTURES;

EID: 70449729461     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.454     Document Type: Review

References (63)

1. Melton LJ, 3rd. Epidemiology of spinal osteoporosis. Spine. 1997;22(24 suppl):2S-11S.
2. Melton LJ 3rd, Lane AW, Cooper C, Eastell R, O'Fallon WM, Riggs BL. Prevalence and incidence of vertebral deformities. Osteoporos Int. 1993; 3(3):113-119.
3. Cooper C, O'Neill T, Silman A. The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group. Bone. 1993;14(suppl 1): S89-S97.
4. Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1999;159(11):1215-1220.
5. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991;114(11):919-923.
6. Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001;285(3):320-323. (Pubitemid 32095035)
7. Gehlbach SH, Bigelow C, Heimisdottir M, May S, Walker M, Kirkwood JR. Recognition of vertebral fracture in a clinical setting. Osteoporos Int. 2000;11(7):577-582. (Pubitemid 30739880)
8. Diamond TH, Champion B, Clark WA. Management of acute osteoporotic vertebral fractures: a nonrandomized trial comparing percutaneous vertebroplasty with conservative therapy. Am J Med. 2003;114(4):257-265. (Pubitemid 36398069)
9. Silverman SL. The clinical consequences of vertebral compression fracture. Bone. 1992;13(suppl 2):S27-S31.
10. Hall SE, Criddle RA, Comito TL, Prince RL. A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int. 1999;9(6):508-515.
11. Salaffi F, Cimmino MA, Malavolta N, et al. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol. 2007;34(7):1551-1560. (Pubitemid 47067994)
12. Silverman SL, Minshall ME, Shen W, Harper KD, Xie S. The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study. Arthritis Rheum 2001; 44(11):2611-2619. (Pubitemid 33049339)
13. Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Int Med. 1998;128:793-800. (Pubitemid 28267711)
14. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 13 1999;353(9156):878-882. (Pubitemid 29126875)
15. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ 3rd. Population-based study of survival after osteoporotic fractures. Am J Epidemiol. 1993;137(9):1001-1005. (Pubitemid 23191067)
16. Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B. Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int. 2004;15(2):108-112. (Pubitemid 38252423)
17. Dolan P, Torgerson DJ. The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int. 1998;8(6):611-617. (Pubitemid 28566979)
18. Gabriel SE, Tosteson AN, Leibson CL, et al. Direct medical costs attributable to osteoporotic fractures. Osteoporos Int. 2002;13(4):323-330.
19. Ray NF, Chan JK, Thamer M, Melton LJ 3rd. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997; 12(1):24-35.
20. Crandall C. Laboratory workup for osteoporosis. Which tests are most cost-effective? Postgrad Med. 2003;114(3):35-38, 41-134
21. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Available at: http://www.nof.org/professionals/ Clinicians-Guide.htm. Accessed February 2009.
22. Holick M, Siris E, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocr Metab. 2005;90:3215-3224. (Pubitemid 41014278)
23. Simonelli CS, Weiss TW, Morancey J, Swanson L, Chen Y. Prevalence of vitamin D inadequacy in a minimal trauma fracture population. Curr Med Res Opin. 2005;21:1069-1074. (Pubitemid 41032697)
24. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA. 1999;281:1505-1511. (Pubitemid 29200934)
25. Edwards BJ, Langman CB, Bunta AD, Vicuna M, Favus M. Secondary contributors for bone loss in osteoporotic hip fractures. Osteoporos Int. 2008;19(7):991-999.
26. Kleerekoper M. Evaluation of the patient with osteoporosis or at risk for osteoporosis. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. Vol.2. San Diego: Academic Press; 2001:403-408.
27. Knopp JA, Diner BM, Blitz M, Lyritis GP, Rowe BH. Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int. 2005;16(10): 1281-1290. (Pubitemid 41396958)
28. Azria M. Possible mechanisms of the analgesic action of calcitonin. Bone. 2002;30(5 suppl):80S-83S. (Pubitemid 34465714)
29. Armingeat T, Brondino R, Pham T, Legre V, Lafforgue P. Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study. Osteoporos Int. 2006;17(11):1659-1665. (Pubitemid 44477627)
30. Allman RM, Goode PS, Patrick MM, Burst N, Bartolucci AA. Pressure ulcer risk factors among hospitalized patients with activity limitation. JAMA. 1995;273(11):865-870.
31. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 17 2003;107(23 suppl 1):I9-I16.
32. Beck-Sague C, Banerjee S, Jarvis WR. Infectious diseases and mortality among US nursing home residents. Am J Public Health. 1993;83(12): 1739-1742. (Pubitemid 24009506)
33. Loeb M, McGeer A, McArthur M, Walter S, Simor AE. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med. 27 1999;159(17): 2058-2064. (Pubitemid 29453594)
34. Malmros B, Mortensen L, Jensen MB, Charles P. Positive effects of physiotherapy on chronic pain and performance in osteoporosis. Osteoporos Int. 1998;8(3):215-221. (Pubitemid 28427070)
35. Bonner FJ Jr, Sinaki M, Grabois M, et al. Health professional's guide to rehabilitation of the patient with osteoporosis. Osteoporos Int. 2003; 14(suppl 2):S1-S22.
36. Mazanec DJ, Podichetty VK, Mompoint A, Potnis A. Vertebral compression fractures: manage aggressively to prevent sequelae. Cleve Clin J Med. 2003;70(2):147-156. Reprinted with permission. Copyright (c) 2003 Cleveland Clinic Foundation. All rights reserved. (Pubitemid 36305268)
37. Morrison WB, Parker L, Frangos AJ, Carrino JA. Vertebroplasty in the United States: guidance method and provider distribution, 2001-2003. Radiology. 2007;243(1):166-170.
38. Gray DT, Hollingworth W, Onwudiwe N, Deyo RA, Jarvik JG. Thoracic and lumbar vertebroplasties performed in US Medicare enrollees, 2001-2005. JAMA. 2007;298(15):1760-1762.
39. Taylor RS, Taylor RJ, Fritzell P. Balloon kyphoplasty and vertebroplasty for vertebral compression fractures: a comparative systematic review of efficacy and safety. Spine. 2006;31(23):2747-2755. (Pubitemid 44673389)
40. Bouza C, Lopez T, Magro A, Navalpotro L, Amate JM. Efficacy and safety of balloon kyphoplasty in the treatment of vertebral compression fractures: a systematic review. Eur Spine J. 2006;15(7):1050-1067. (Pubitemid 44078259)
41. Hulme PA, Krebs J, Ferguson SJ, Berlemann U. Vertebroplasty and kyphoplasty: a systematic reviewof 69 clinical studies. Spine. 2006;31(17):1983-2001. (Pubitemid 44297781)
42. Voormolen MH, Mali WP, Lohle PN, et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short-term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. AJNR Am J Neuroradiol. 2007;28(3):555-560.
43. Lavelle WF, Cheney R. Recurrent fracture after vertebral kyphoplasty. Spine J. 2006;6(5):488-493.
44. Trout AT, Kallmes DF. Does vertebroplasty cause incident vertebral fractures? A review of available data. AJNR Am J Neuroradiol. 2006;27(7): 1397-1403.
45. Centers forMedicare andMedicaid Services. Agency for Healthcare Research and Quality (AHRQ). Technology Assessment. Percutaneous Kyphoplasty for Vertebral Fractures Caused by Osteoporosis and Malignancy, 2005. Available at: http://www.cms.hhs.gov/mcd/viewtechassess.asp?from2=viewtechassess. asp&where=index&tid=25&. Accessed February 2009.
46. Hollingworth W, Jarvik JG. Evidence on the effectiveness and cost-effectiveness of vertebroplasty: a review of policy makers' responses. Acad Radiol. 2006;13(5):550-555.
47. Kallmes DF. Randomized vertebroplasty trials: current status and challenges. Acad Radiol. 2006;13(5):546-549. (Pubitemid 44313789)
48. Klazen CA, Verhaar HJ, Lampmann LE, et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials. 2007;8(1):33.
49. Buchbinder R, Osborne RH. Vertebroplasty: a promising but as yet unproven intervention for painful osteoporotic spinal fractures. Med J Aust. 2006;185(7):351-352. (Pubitemid 44540793)
50. Andrade SE, Majumdar SR, Chan KA, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med. 2003;163(17):2052-2057. (Pubitemid 37151247)
51. Kamel HK, Hussain MS, Tariq S, Perry HM, Morley JE. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med. 2000;109(4):326-328.
52. Smith MD, Ross W, Ahern MJ. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip andwrist fractures. J Rheumatol. 2001;28(11):2504-2508. (Pubitemid 33031983)
53. Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J. Underuse of osteoporosis medications in elderly patients with fractures. Am J Med. 2003;115(5):398-400. (Pubitemid 37311258)
54. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348(9041): 1535-1541.
55. Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C. Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev. 2002; 23(4):570-578.
56. Guyatt GH, Cranney A, Griffith L, et al. Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures. Endocrinol Metab Clin North Am. 2002;31(3): 659-679, xii. (Pubitemid 35006615)
57. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999;282(14):1344-1352.
58. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344(5):333-340.
59. Chesnut IC, Skag A, Christiansen C, et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004;19(8):1241-1249. (Pubitemid 41094364)
60. Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 3 2007;356(18): 1809-1822. (Pubitemid 46698462)
61. Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med. 2005;353(6):595-603.
62. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis.Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. [Review]. Arthritis Rheum. 2001; 44(7):1496-1503.
63. Edwards BJ, Bunta AD, Madison LD, et al. An osteoporosis and fracture intervention program increases the diagnosis and treatment for osteoporosis for patients with minimal trauma fractures. Jt Comm J Qual Patient Saf. 2005; 31(5):267-274.